Clinical Trials Directory

Trials / Completed

CompletedNCT01964521

TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended

An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Molnlycke Health Care AB · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

An open, non-comparative, multi-centre post marketing clinical follow-up, PMCF, investigation to evaluate performance and safety on diabetic foot ulcer, dfu, when using mepilex transfer Ag as intended.

Detailed description

Approximately 25-30 subjects from two to three centers will be evaluated provided they fulfill the inclusion criteria and none of the exclusion criteria and gives a signed and dated consent. Subjects to be included were to suffer from a DFU and being in need of anti-microbial wound dressing. Dressing changes were to performed according to the local clinical routine (usually 3 times/week), evaluated during a total treatment period of maximum 4 weeks including weekly visits when assessments were being done. A record (dressing log) for Mepilex Transfer Ag and outer layers were to be filled in at every dressing change. Photos taken directly upon dressing removal and after cleansing /debridement were to be collected to visually follow the ulcers status. At each visit the investigators/nurse and subjects opinion (using an evaluation form) were to be asked for questions considering the use of Mepilex Transfer Ag. Pain before, during and after removal will be assessed.

Conditions

Interventions

TypeNameDescription
DEVICEMepilex Transfer AgA soft silicone wound contact layer that absorbs and transfers exudate, maintains a moist wound healing environment and has antimicrobial properties.

Timeline

Start date
2014-02-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2013-10-17
Last updated
2018-08-10
Results posted
2018-08-10

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01964521. Inclusion in this directory is not an endorsement.